ORAMED PHARMACEUTICALS INC (ORMP) Stock News

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral...

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the second quart...

3 Micro-Cap Moonshots for Fearless Investors

Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.

Oramed Letter to Shareholders

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed") (www.oramed.com), a clinical-stage pharmaceutical company focused on the...

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the first quarte...

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the fourth quart...

Oramed Letter to Shareholders

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

/PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has...

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving...

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex")...

Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) announced today that it has signed a non-binding term sheet with Hefei...

Oramed to Present at the 83rd American Diabetes Association Conference

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract...

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will...

Oramed's Chinese partner HTIT completes phase 3 oral insulin trial (NASDAQ:ORMP)

Oramed Pharmaceuticals (ORMP) has announced the successful completion of Phase 3 trials for oral insulin in type 2 diabetes in China by its strategic partner, Hefei Tianhui...

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) announced today that Hefei Tianhui Biotechnology Co. Ltd. (HTIT), a...

Investing millions, Ben Shapiro joins board of Oramed Pharmaceuticals

Conservative political commentator and entrepreneur, Ben Shapiro, has taken a $4.7M stake in struggling Israeli pharmaceutical company Oramed Pharmaceuticals. Read more here.

Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company

Right-wing media entrepreneur Ben Shapiro has taken a $4.7 million stake in a struggling Israeli pharmaceutical company and joined the board.

Oramed Pharmaceuticals Issues Shareholder Update

/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it continues to conduct a comprehensive analysis...

Hot Stocks: CTSH rises on guidance; LOGI slumps; CAT hits 52-week high; ORMP plunges 76%

CAT set a 52-week high. CTSH rose on guidance and a leadership change. LOGI falls on a weak forecast. ORMP plunged 76% on clinical data.